CIBC Private Wealth Group
NVCR icon

CIBC Private Wealth Group’s NovoCure NVCR Stock Holding History

CIBC Private Wealth Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.6K Hold
124
– – ﹤0.01% 2838
2025
Q3 		$1.6K Hold
124
– – ﹤0.01% 2760
2025
Q2 		$2.21K Sell
124
-1,233
-91% -$21.5K ﹤0.01% 2620
2025
Q1 		$20.9K Buy
+1,357
New +$30.8K ﹤0.01% 1972
2024
Q3 		– Sell
-192
Closed -$3.07K – 3241
2024
Q2 		$3.07K Sell
192
-17
-8% -$299 ﹤0.01% 2670
2024
Q1 		$3.24K Buy
+209
New +$3.07K ﹤0.01% 2635
2021
Q3 		– Sell
-3,347
Closed -$742K – 994
2021
Q2 		$742K Buy
+3,347
New +$651K ﹤0.01% 725

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CIBC Private Wealth Group's NVCR Position: Q4 2025 in Review

CIBC Private Wealth Group held its NovoCure (NVCR) position steady in Q4 2025 at 124 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2838.

CIBC Private Wealth Group first reported a position in NVCR in Q2 2021 and has held it in 7 quarters since. The position peaked at $742K in Q2 2021. 238 funds tracked by Wall St. Rank hold NVCR as of Q4 2025.

  • CIBC Private Wealth Group held 124 shares of NovoCure worth $1.6K as of Q4 2025.
  • CIBC Private Wealth Group left its NovoCure share count unchanged in Q4 2025.
  • NovoCure made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2838 holding.
  • CIBC Private Wealth Group first reported a position in NovoCure in Q2 2021 and has held it in 7 quarters since.
  • CIBC Private Wealth Group's NovoCure position peaked at $742K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held NovoCure as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.